Signal
United Therapeutics has linked a once-daily drug candidate to a 55% drop in the risk of clinical worsening in a phase 3 trial, setting the company up to seek...
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-03-02 16:07 UTCUpdated 2026-03-02 16:32 UTC
rss
fierce_biotech
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (2 domains)domains are deduped. counts indicate coverage, not truth.2 top sources shown
limited source diversity in top sources
Overview
United's PAH drug clears phase 3 trial, setting up filings Phil.Taylor Mon, 02/03/2026 - 16:32.
Score total
0.98
Momentum 24h
2
Posts
2
Origins
2
Source types
1
Duplicate ratio
0%
All evidence
All evidence
United's PAH drug clears phase 3 trial, setting up filings
pharmaphorum · pharmaphorum.com · 2026-03-02 16:32 UTC
United Therapeutics has linked a once-daily drug candidate to a 55% drop in the risk of clinical worsening in a phase 3 trial, setting the company up to seek FDA approval in pul...
Fierce Biotech · fiercebiotech.com · 2026-03-02 16:07 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- pharmaphorum (1)
- Fierce Biotech (1)
Top origin domains (this list)
- pharmaphorum.com (1)
- fiercebiotech.com (1)